MAPT and dementia: However, in this previous study they investigated combined Aβ- and tau- norms, instead of only Aβ- norms, and validated the norms in a preclinical cohort with progression to CDR ≥ 0.5 as an outcome, whereas we validated our norms in a large memory clinic cohort with progression to dementia as an outcome.